BJOG: An International Journal of Obstetrics and Gynaecology 2009-10-01

The use of misoprostol in obstetrics and gynaecology.

A Elati, A D Weeks

Index: BJOG 116 , 61-69, (2009)

Full Text: HTML

Abstract

Misoprostol, although originally introduced as a therapy for gastric ulcers, is now widely used in reproductive health. For some indications it is now the optimal choice, whilst for others it provides an important alternative, especially in low-resource settings. The optimal dose varies widely from 20 to 600 mcg depending on the indication and gestation. Use of the correct dose is important, too low a dose will be ineffective and overdosage can be dangerous for mother and baby. Evidence-based information about the safest regimens for multiple pregnancy indications are therefore provided in this review.


Related Compounds

Related Articles:

Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.

2009-10-01

[J. Obstet. Gynaecol. Can. 31 , 980-993, (2009)]

Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.

2009-01-01

[Drugs 69 , 51-69, (2009)]

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.

1988-12-03

[Lancet 2 , 1277, (1988)]

Misoprostol for the prevention and treatment of postpartum hemorrhage.

2012-02-01

[Expert Opin. Investig. Drugs 21 , 235-250, (2012)]

More Articles...